RIOT BLOCKCHAIN, INC.

Profile

Company Names

RIOT BLOCKCHAIN, INC.
BIOPTIX, INC.
VENAXIS, INC.

Addresses

202 6TH STREET, SUITE 401, CASTLE ROCK, CO 80104

1775 38TH STREET, BOULDER, CO 80301

1585 S. PERRY STREET, CASTLE ROCK, CO 80104

Phone Numbers

303-794-2000
303-545-5550
(303) 794-2000

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, OTHER, BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

COLORADO

Total Amount Raised:

$53,047,660.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-01-28 
$7,060,132.00 
$7,060,132.00 
$0.00 
Equity, Debt 
4
2017-12-21 
$37,037,528.00 
$37,037,528.00 
$0.00 
Equity 
3
2017-03-16 
$4,750,000.00 
$4,750,000.00 
$0.00 
Debt 
2
2017-03-10 
$2,250,000.00 
$2,250,000.00 
$0.00 
Equity 
1
2016-09-12 
$1,950,000.00 
$1,950,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
M. 
BEEGHLEY 
DIRECTOR
ROB 
 
CHANG 
EXECUTIVE OFFICER
MIKE 
T. 
DAI 
DIRECTOR
SUSAN 
A. 
EVANS 
DIRECTOR
DARYL 
J. 
FAULKNER 
DIRECTOR
JASON 
 
LES 
DIRECTOR, EXECUTIVE OFFICER
STEPHEN 
T. 
LUNDY 
EXECUTIVE OFFICER, DIRECTOR
REMO 
 
MANCINI 
EXECUTIVE OFFICER
JEFFREY 
G. 
MCGONEGAL 
EXECUTIVE OFFICER
JOHN 
R. 
O-ROURKE 
EXECUTIVE OFFICER, DIRECTOR
GAIL 
S. 
SCHOETTLER 
DIRECTOR
DAVID 
E. 
WELCH 
DIRECTOR
STEPHEN 
A. 
WILLIAMS 
DIRECTOR
BENJAMIN 
 
YI 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-01-28 
D
OTHER 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2017-12-21 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2017-03-10 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Debt 
2017-03-16 
D
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2016-09-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#